Penumbra Inc (PEN) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.030x

Based on the latest financial reports, Penumbra Inc (PEN) has a cash flow conversion efficiency ratio of 0.030x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($46.08 Million) by net assets ($1.53 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Penumbra Inc for the company's overall valuation and market capitalisation.

Penumbra Inc - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Penumbra Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Penumbra Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Penumbra Inc ranked by their cash flow conversion efficiency. Explore PEN cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Grab Holdings Ltd
NASDAQ:GRAB
0.014x
Turkiye Garanti Bankasi A.S.
IS:GARAN
0.249x
SK Telecom Co Ltd
KO:017670
0.078x
Xian LONGi Silicon Materials Corp
SHG:601012
0.045x
One 97 Communications Limited
NSE:PAYTM
0.003x
Graco Inc
NYSE:GGG
0.066x
LPP S.A.
WAR:LPP
0.432x
McCormick & Company Incorporated
NYSE:MKC
0.050x

Annual Cash Flow Conversion Efficiency for Penumbra Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Penumbra Inc from 2013 to 2025. View latest Penumbra Inc stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.43 Billion $238.66 Million 0.167x +14.20%
2024-12-31 $1.15 Billion $168.48 Million 0.146x +77.31%
2023-12-31 $1.18 Billion $97.33 Million 0.083x +248.16%
2022-12-31 $998.86 Million $-55.66 Million -0.056x -659.43%
2021-12-31 $953.93 Million $9.50 Million 0.010x +119.11%
2020-12-31 $637.79 Million $-33.24 Million -0.052x -194.97%
2019-12-31 $485.61 Million $26.65 Million 0.055x -19.52%
2018-12-31 $422.42 Million $28.81 Million 0.068x +115.17%
2017-12-31 $400.41 Million $12.69 Million 0.032x +165.97%
2016-12-31 $266.55 Million $-12.81 Million -0.048x +49.85%
2015-12-31 $232.52 Million $-22.28 Million -0.096x -118.55%
2014-12-31 $-12.37 Million $-6.39 Million 0.516x +22.61%
2013-12-31 $-8.06 Million $-3.40 Million 0.421x --

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.58 Billion
Market Cap Rank
#1883 Global
#708 in USA
Share Price
$319.39
Change (1 day)
+0.19%
52-Week Range
$225.54 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more